AFIA
REGN icon

America First Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

America First Investment Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-60
Closed -$25K – 137
2014
Q4 		$25K Hold
60
– – 0.01% 92
2014
Q3 		$22K Hold
60
– – 0.01% 109
2014
Q2 		$17K Sell
60
-15
-20% -$4.45K 0.01% 111
2014
Q1 		$23K Hold
75
– – 0.01% 104
2013
Q4 		$21K Hold
75
– – 0.01% 116
2013
Q3 		$23K Buy
+75
New +$19.7K 0.01% 111

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

America First Investment Advisors's REGN Position: Q1 2015 in Review

America First Investment Advisors sold out of Regeneron Pharmaceuticals (REGN) in Q1 2015, closing a stake of 60 shares — an estimated $25K sold.

America First Investment Advisors first reported a position in REGN in Q3 2013 and held it in 6 quarters. The position peaked at $25K in Q4 2014. 509 funds tracked by Wall St. Rank hold REGN as of Q1 2015.

  • America First Investment Advisors reported no remaining Regeneron Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • America First Investment Advisors sold 60 Regeneron Pharmaceuticals shares in Q1 2015, an estimated $25K.
  • America First Investment Advisors first reported a position in Regeneron Pharmaceuticals in Q3 2013 and held it in 6 quarters.
  • America First Investment Advisors's Regeneron Pharmaceuticals position peaked at $25K in Q4 2014.
  • 509 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2015.

Based on America First Investment Advisors's 13F filing for Q1 2015, filed 29 Apr 2015.